Table 3

Association of various risk factors and interval cancer after colonoscopy in study population

Risk factorsWhole cohortSubjects with negative colonoscopy
Univariate analysisMultivariable analysisUnivariate analysisMultivariable analysis
Crude RR (95% CI)Adjusted RR (95% CI)Crude RR (95% CI)Adjusted RR (95% CI)
Age, years
 60–69 vs 50–591.58 (1.16 to 2.16)1.49 (1.09 to 2.04)1.87 (1.23 to 2.84)1.82 (1.19 to 2.78)
Gender
 Male vs female1.20 (0.88 to 1.63)---1.37 (0.90 to 2.07)
Faecal haemoglobin concentration (μg Hb/g faeces)
 20–491.001.001.001.00
 50–991.41 (0.88 to 2.24)1.48 (0.93 to 2.37)1.49 (0.81 to 2.74)1.58 (0.85 to 2.92)
 100–1492.45 (1.46 to 4.11)2.55 (1.52 to 4.29)2.30 (1.13 to 4.69)2.45 (1.20 to 5.02)
 ≥1502.54 (1.72 to 3.76)2.74 (1.84 to 4.09)2.60 (1.55 to 4.37)2.88 (1.70 to 4.90)
Received colonoscopy in settings with adenoma detection rate (%)
 >301.001.001.001.00
 15–301.44 (0.89 to 2.33)1.57 (0.94 to 2.61)2.06 (0.90 to 4.73)1.90 (0.83 to 4.39)
 <152.58 (1.33 to 5.01)3.09 (1.55 to 6.18)3.75 (1.39 to 10.13)3.61 (1.33 to 9.81)
Index colonoscopy findings
 No adenoma1.001.00
 Non-advanced adenoma only1.44 (1.01 to 2.05)1.52 (1.06 to 2.18)
 Advanced adenoma2.26 (1.45 to 3.51)1.87 (1.19 to 2.96)
  • Ambient temperature and FIT kit brand were included in the analyses, and both univariate analyses revealed no significant impact of these factors.

  • FIT, faecal immunochemical testing; RR, relative risk.